Rich Allan | IR |
Dinesh Patel | President and CEO |
Don Kalkofen | Senior Advisor, Finance and Accounting |
Richard Shames | CMO |
David Liu | CSO and Head, Research & Development |
George Farmer | BMO Capital Markets |
Joseph Schwartz | SVB Leerink |
Jackson Harvey | Nomura Instinet |
Timothy Chiang | BTIG |
Adam Walsh | Stifel |
Good day and welcome to the Protagonist Therapeutics' Year End 2018 Update Call. Please note that today's conference is being recorded. [Operator Instructions] At this time, I would like to introduce Rich Allan of Protagonist Therapeutics Investor Relations. Please go ahead.
Thank you, operator.